dc.contributor.author | Ubah, Obinna C | |
dc.contributor.author | Lake, Eric W | |
dc.contributor.author | Gunaratne, Gihan S | |
dc.contributor.author | Gallant, Joseph P | |
dc.contributor.author | Fernie, Marie | |
dc.contributor.author | Robertson, Austin J | |
dc.contributor.author | Marchant, Jonathan S | |
dc.contributor.author | Bold, Tyler D | |
dc.contributor.author | Langlois, Ryan A | |
dc.contributor.author | Matchett, William E | |
dc.contributor.author | Thiede, Joshua M | |
dc.contributor.author | Shi, Ke | |
dc.contributor.author | Yin, Lulu | |
dc.contributor.author | Moeller, Nicholas H | |
dc.contributor.author | Banerjee, Surajit | |
dc.contributor.author | Ferguson, Laura | |
dc.contributor.author | Kovaleva, Marina | |
dc.contributor.author | Porter, Andrew J | |
dc.contributor.author | Aihara, Hideki | |
dc.contributor.author | LeBeau, Aaron M | |
dc.contributor.author | Barelle, Caroline J | |
dc.date.accessioned | 2021-12-23T11:21:01Z | |
dc.date.available | 2021-12-23T11:21:01Z | |
dc.date.issued | 2021-12-16 | |
dc.identifier.citation | Ubah , O C , Lake , E W , Gunaratne , G S , Gallant , J P , Fernie , M , Robertson , A J , Marchant , J S , Bold , T D , Langlois , R A , Matchett , W E , Thiede , J M , Shi , K , Yin , L , Moeller , N H , Banerjee , S , Ferguson , L , Kovaleva , M , Porter , A J , Aihara , H , LeBeau , A M & Barelle , C J 2021 , ' Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography ' , Nature Communications , vol. 12 , no. 1 , 7325 . https://doi.org/10.1038/s41467-021-27611-y | en |
dc.identifier.issn | 2041-1723 | |
dc.identifier.other | PURE: 210581659 | |
dc.identifier.other | PURE UUID: 3966c028-7a55-4d52-b341-224a6c667849 | |
dc.identifier.other | PubMed: 34916516 | |
dc.identifier.other | Scopus: 85121420979 | |
dc.identifier.uri | https://hdl.handle.net/2164/17761 | |
dc.description | Acknowledgements This work was supported by the Chief Scientist Office, Scottish Government, Grant COV/ABN/20/01 (Elasmogen, Ltd.), a 2018 Prostate Cancer Foundation Challenge Award (AML), a 2013 Prostate Cancer Foundation Young Investigator Award (AML), NCI R01s CA237272, CA233562, and CA245922 (AML). WEM was supported by the NIH T32 HL007741 and JMT by the NIH T32 AI055433. JSM was funded by NIGMS R01 GM088790. HA was funded by NIGMS R35 GM118047 and NCI P01 CA234228. X-ray diffraction data were collected at the Northeastern Collaborative Access Team beamlines, which are funded by the US National Institutes of Health (NIGMS P30 GM124165). The Pilatus 6M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). We thank the Marco Pravetoni lab for providing training and access to the OctetRED96e for BLI experiments. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nature Communications | en |
dc.rights | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Antibody fragment therapy | en |
dc.subject | Protein design | en |
dc.subject | R Medicine | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject | COV/ABN/20/01 | en |
dc.subject | Prostate Cancer UK | en |
dc.subject | CA245922 | en |
dc.subject | CA233562 | en |
dc.subject | NCI R01s CA237272 | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1038/s41467-021-27611-y | |
dc.identifier.vol | 12 | en |
dc.identifier.iss | 1 | en |